By Josh White
Date: Monday 30 Sep 2024
(Sharecast News) - Alliance Pharma reported a 2.8% increase in revenue on Monday, to £84.8m on a see-through basis, driven by the robust performance of its Kelo-Cote franchise.
By Josh White
Date: Monday 29 Jul 2024
(Sharecast News) - Alliance Pharma said in a half-year trading update on Monday that its revenue rose to £84.8m, a 2.8% increase year-on-year, and a 5% increase at constant exchange rates.
By Josh White
Date: Tuesday 23 Jul 2024
(Sharecast News) - Healthcare products group Alliance Pharma announced on Tuesday that its chief operating officer Jeyan Heper would leave the company on 31 August.
Currency | UK Pounds |
Share Price | 45.65p |
Change Today | -0.100p |
% Change | -0.22 % |
52 Week High | 49.55 |
52 Week Low | 29.35 |
Volume | 678,755 |
Shares Issued | 540.57m |
Market Cap | £246.77m |
Beta | 0.95 |
RiskGrade | 119 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 4 |
Buy | 0 |
Neutral | 3 |
Sell | 0 |
Strong Sell | 0 |
Total | 7 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 22-Jun-23 | 22-Dec-22 |
Paid | 18-Jul-23 | 19-Jan-23 |
Amount | 1.18p | 0.59p |
Time | Volume / Share Price |
15:39 | 12 @ 45.56p |
15:23 | 3,250 @ 45.70p |
15:06 | 2,641 @ 45.80p |
15:00 | 38,193 @ 45.37p |
14:52 | 5 @ 45.27p |
CFO | Andrew Franklin |
Chair | Camillo Pane |
CEO | Nick Sedgwick |
You are here: research